Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis

Mohamed El-Tanani1, Hamdi Nsairat2, Alaa A Aljabali3

  • 1Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan; Institute of Cancer Therapeutics, University of Bradford, Bradford, West Yorkshire BD7 1DP, United Kingdom.

Life Sciences
|April 7, 2023
PubMed

Insights

The mammalian target of rapamycin (mTOR) pathway regulates cell proliferation. Deregulation of this crucial signaling pathway is linked to cancer growth and progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The mammalian target of rapamycin (mTOR) is a key signaling pathway involved in regulating cell proliferation and growth.
  • mTOR integrates signals from growth factors, nutrients, and cellular stress.
  • Aberrant mTOR signaling is implicated in various human diseases, particularly cancer.

Purpose of the Study:

  • To review the normal physiological functions of the mTOR pathway.
  • To elucidate the role of mTOR deregulation in cancer development and progression.
  • To provide a comprehensive overview of mTOR signaling in both normal and cancerous states.

Main Methods:

  • Literature review of existing scientific publications.
  • Analysis of studies investigating mTOR pathway components and functions.
  • Synthesis of information on mTOR's role in cell proliferation and cancer.

Main Results:

  • mTOR is essential for normal cellular processes, including protein synthesis, cell growth, and metabolism.
  • Dysregulation of the mTOR pathway, including hyperactivation, is frequently observed in diverse types of cancer.
  • The PI3K-AKT pathway is a major upstream regulator of mTOR activity, responding to various stress signals.

Conclusions:

  • The mTOR pathway is a critical regulator of cell proliferation with vital roles in normal physiology.
  • Aberrant mTOR signaling is a significant driver of tumorigenesis and cancer progression.
  • Targeting the mTOR pathway presents a promising therapeutic strategy for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K